MEDP · Medpace Holdings, Inc. · Documents
$692.68
+18.89 (+2.80%)
At close · Oct 28
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$18.85B
Shares
27.97M
Volume · Oct 28
301.64K
Avg daily vol (3M)
265.06K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | Medpace reported nine-month revenue of $2,129.9 million, net income of $382.7 million and operating cash flow of $530.4 million for the period ended September 30, 2026. Backlog reached $3,167.2 million, and the Board authorized up to $1.0 billion in share repurchases. | 2026-10-22 | 2026-09-30 | |
| 8-K | Medpace Holdings, Inc. reported third-quarter 2026 revenue of $716.0 million, up 8.5%, and GAAP net income of $137.5 million, or $4.84 per diluted share. The board authorized up to $1.0 billion of share repurchases through December 31, 2028. | 2026-10-21 | 2026-10-20 | |
| 10-Q | — | 2026-07-23 | 2026-06-30 | |
| 8-K | — | 2026-07-22 | — | |
| 8-K | — | 2026-06-04 | 2026-06-01 | |
| 8-K | — | 2026-05-19 | 2026-05-15 | |
| Investor Event Transcript | — | 2026-05-15 | 2026-06-30 | |
| 10-Q | — | 2026-04-23 | 2026-03-31 | |
| 8-K | — | 2026-04-22 | 2026-04-21 | |
| ARS | — | 2026-04-01 | 2025-12-31 | |
| DEF 14A | — | 2026-04-01 | 2026-05-15 | |
| DEFA14A | — | 2026-04-01 | — | |
| PRE 14A | — | 2026-03-16 | 2026-05-15 | |
| 10-K | — | 2026-02-10 | 2025-12-31 | |
| 8-K | — | 2026-02-09 | — | |
| 10-Q | — | 2025-10-23 | 2025-09-30 | |
| 8-K | — | 2025-10-22 | — | |
| 10-Q | — | 2025-07-22 | 2025-06-30 | |
| 8-K | — | 2025-07-21 | 2025-07-17 | |
| 8-K | — | 2025-05-16 | — | |
| 10-Q | — | 2025-04-22 | 2025-03-31 | |
| 8-K | — | 2025-04-21 | 2025-04-17 | |
| DEF 14A | — | 2025-04-02 | 2024-12-31 | |
| DEFA14A | — | 2025-04-02 | — | |
| ARS | — | 2025-04-02 | 2024-12-31 | |
| 8-K | — | 2025-03-31 | 2025-03-28 | |
| 10-K | — | 2025-02-11 | 2024-12-31 | |
| 8-K | — | 2025-02-10 | 2025-02-06 | |
| 10-Q | — | 2024-10-22 | 2024-09-30 | |
| 8-K | — | 2024-10-21 | — | |
| 10-Q | — | 2024-07-23 | 2024-06-30 | |
| 8-K | — | 2024-07-22 | — | |
| 8-K | — | 2024-07-03 | 2024-06-28 | |
| 8-K | — | 2024-05-21 | 2024-05-17 | |
| 10-Q | — | 2024-04-23 | 2024-03-31 | |
| 8-K | — | 2024-04-22 | — | |
| DEF 14A | — | 2024-04-03 | 2024-05-17 | |
| ARS | — | 2024-04-03 | 2023-12-31 | |
| DEFA14A | — | 2024-04-03 | — | |
| 8-K | — | 2024-03-29 | 2024-03-28 | |
| PRE 14A | — | 2024-03-20 | 2024-05-17 | |
| 10-K | — | 2024-02-13 | 2023-12-31 | |
| 8-K | — | 2024-02-12 | — | |
| 10-Q | — | 2023-10-24 | 2023-09-30 | |
| 8-K | — | 2023-10-23 | — | |
| 10-Q | — | 2023-07-25 | 2023-06-30 | |
| 8-K | — | 2023-07-24 | — | |
| 8-K | — | 2023-05-19 | — | |
| 10-Q | — | 2023-04-25 | 2023-03-31 | |
| 8-K | — | 2023-04-24 | — |
Showing 1–50 of 104 filings
Key facts
CIK
1668397
CUSIP
58506Q109
13F (30d)
190 filings
181 filers
Visit website
Investor relations